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ABSTRACT 
 
We developed a new 2-day protocol for the generation of dendritic cells (DCs) from human monocytes in vitro. First, we demonstrated 
that 24 hours of culture with GM-CSF and IL-4 are sufficient to generate immature DCs capable of antigen uptake. We then compared 
two different strategies for DC maturation: proinflammatory mediators were either added together with GM-CSF and IL-4 from the 
beginning of cell culture or added after 24 hours of differentiation with GM-CSF and IL-4. After 48 hours of total culture period, 
expression of activation markers was more pronounced in cells generated by the 2-step differentiation and activation method. Our new 
protocol for 2-day DC differentiation reduces labor, cost and time and also reliably renders high numbers of mature and viable DCs. 
 
 
INTRODUCTION 
 
Dendritic cells (DCs) are highly specialized antigen presenting 
cells that possess the unique ability to initiate primary immune 
responses. Immature DCs reside in peripheral tissues where they 
take up and process antigen for presentation on MHC molecules 
(1). In response to inflammatory, microbial or T-cell derived 
stimuli, maturation of DCs is induced. Upon maturation, they 
upregulate MHC molecules as well as various adhesion and 
costimulatory molecules and thus become potent stimulators of 
naïve T cells (2, 3). 
 
Circulating DCs in human blood are rare (< 1% of human 
PBMC) and difficult to maintain in culture. Therefore, monocytes 
are used as progenitors for the in vitro generation of DCs (4, 5). 
Commonly, monocytes are cultured with GM-CSF and IL-4 for 5 
to 7 days followed by stimulation for another 2 to 3 days 
(moDCs). Obermaier et al.    
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There is increasing evidence that the time span required for DC 
differentiation in vivo may be shorter. It has been shown that a 
subpopulation of monocytes differentiated into mature DCs 
upon reverse transmigration across an endothelial barrier within 
48 hours (6). Moreover, GM-CSF-cultured monocytes activated 
with calcium ionophore or CD40L rapidly express mature DC 
surface markers (7, 8). Santini et al. showed that culture of GM-
CSF-treated monocytes with type I Interferon induced DC 
maturation within 3 days without the need for further stimulation 
(15). These cells upregulated the costimulatory molecules CD80, 
CD86 and CD40 and the antigen-presenting molecule MHCII, 
but only moderately expressed the mature DC surface marker 
CD83.  
 
The aim of this study was to develop a protocol of accelerated 
DC maturation in vitro. We compared two different approaches to 
generate dendritic cells from monocytes within 48 hours trying to 
reflect a potential in vivo process of DC differentiation. 
Furthermore, we identified an optimal combination of 
proinflammatory mediators for stimulation and tested the 
endocytic capacity of DCs generated according to the new 
protocol. Our results show that fully functional dendritic cells 
can be generated within 48 hours from monocytes. This protocol 
represents a cost-effective and reliable alternative to the 
traditional standard protocols. 
 
MATERIALS AND METHODS 
 
Reagents and ELISA kits 
 
Recombinant cytokines: GM-CSF was purchased from Novartis 
(Basel, Switzerland), IL-4 from Promega (Madison, WI), TNF-α 
from R&D Systems (Wiesbaden, Germany) and IL-6 from 
Amersham (Buckinghamshire, UK); IL-1β was obtained from 
Strathmann Biotech (Hannover, Germany). PGE2 and FITC-
dextran were purchased from Sigma-Aldrich (Steinheim, 
Germany). Soluble CD40 ligand-trimer (CD40L) was a generous 
gift of Immunex, Seattle, WA. Total IL-12 was determined using 
an assay that detects both IL-12 (p40) and IL-12 (p70) (Bender 
Med Systems, Vienna, Austria). IL-12 (p70) and IL-12 (p40) were 
measured separately using OptEIA human IL-12 (p70) or IL-12 
(p40) set form Pharmingen (San Diego, CA). 
 
Media 
 
All cultures of human PBMC were maintained in RPMI 1640 
medium (Biochrom, Berlin, Germany) supplemented with 2% 
human AB serum (BioWhittaker, Walkersville, MD), 2 mM L-
glutamine (Life Technologies, Paisley, Scotland), 50 U/ml 
penicillin and 50 µg/ml streptomycin (Sigma, Munich, Germany), 
hereafter referred to as complete medium. 
 
Isolation and culture of cells (see Protocol 1 & 2) 
 
In short, PBMC were isolated from peripheral blood of healthy 
donors by Ficoll-hypaque gradient centrifugation. Monocytes 
were purified either by using the MACS CD14 isolation kit 
(Miltenyi Biotec, Bergisch Gladbach, Germany) or by collecting 
the plastic adherent fraction of PBMC as described (9). 
Subsequently, monocytes were cultured in six-well plates (0.5 to 
1.5 x 106 cells/ml) in fresh complete medium supplemented with 
1000 U/ml GM-CSF and 500 U/ml IL-4. To generate standard 
monocyte-derived DCs (moDCs), cells were cultured for 6 days 
and subsequently incubated with a combination of 
proinflammatory mediators for 24 hours (1000 U/ml TNF-α, 10 
ng/ml IL-1β, 10 ng/ml IL-6 plus 1 µM PGE2). Alternatively, two 
different approaches were made to accelerate DC maturation: 
monocytes were cultured with GM-CSF (1000 U/ml) and IL-4 
(500 U/ml). The proinflammatory mediators were either added at 
the initiation of culture or after 24 hours of incubation. In both 
cases, cells were harvested after a total culture period of 48 hours.  
 
Flow cytometry and monoclonal antibodies 
 
The following monoclonal antibodies were used for FACS 
analysis: TÜ39 (anti-HLA DR, DP, DQ, FITC-conjugated), 
L307.4 (anti-CD80, PE-conjugated), 2331/FUN-1 (anti-CD86, 
APC-conjugated), HB15e (anti-CD83, FITC-conjugated) and 
M5E2 (anti-CD14, APC-conjugated). 
 
Measurement of FITC-dextran uptake 
 
Endocytic activity was assessed by incubating cells for 2 hours 
w i t h  F I T C - d e x t r a n  ( 0 . 5  m g / m l )  a t  3 7 ° C .  C e l l s  w e r e  w a s h e d  
extensively with PBS and FITC-dextran uptake was quantified as 
mean fluorescence intensity (MFI) (nonspecific FITC signal was 
assessed by incubating cells on ice). 
 
Statistical analysis 
 
Data are expressed as means ± SEM. Statistical significance was 
determined using the paired two-tailed Student’s t test. 
Differences were considered statistically significant for p < 0.05. 
Significance is presented for individual experiments (asterisks in 
figures). Statistical analysis was performed using Stat-View 4.51 
software (Abacus Concepts, Calabasas, CA, USA). 
 
RESULTS AND DISCUSSION 
 
Development of a new method of accelerated DC 
maturation 
 
Monocytes were isolated from PBMC by using the MACS CD14 
isolation kit or by collecting the plastic adherent fraction of 
PBMC (Protocol 1). Monocytes were either cultured with GM-
CSF and IL-4 for 48 hours (immature DCs) (Fig. 1, top), or with 
GM-CSF and IL-4 plus proinflammatory mediators (TNF-α, IL-
1β, IL-6 plus PGE2) for 48 hours (Fig. 1, middle), or cultured for 
24 hours with GM-CSF and IL-4 and subsequently stimulated 
with proinflammatory mediators for another 24 hours (Fig. 1, Obermaier et al.    
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bottom). Monocytes cultured with GM-CSF and proinflammatory 
mediators only (without IL-4) served as a control group. 
 
Fig. 1: Two different strategies were tested to identify an optimal protocol 
for the generation of dendritic cells from monocytes within 48 hours. 
M o n o c y te s  w e r e  c u l t u r e d  w i t h  G M - C S F  a n d  I L - 4  t o  g e n e r a te  i m m a t u r e  D C s 
(top). To accelerate DC-maturation, monocytes were either stimulated with 
proinflammatory mediators from the initiation of culture (middle) or they were 
stimulated with the proinflammatory mediators after 24 hours of culture with 
GM-CSF/IL-4 (bottom). All cell populations were harvested after a total culture 
period of 48 hours to assess phenotype and function. 
 
Cells cultured with GM-CSF and IL-4 only downregulated CD 
14, expressed moderate levels of CD86 and MHCII and stayed 
CD83 negative corresponding to an immature DC 
immunophenotype. To determine the minimal time span 
required for DC maturation, cells cultured with GM-CSF and IL-
4 plus proinflammatory mediators were harvested and tested for 
the expression of surface markers at various time points: after 12, 
24, 48 and 72 hours of total culture period. After 48 hours, we 
noted changes typical for mature DCs in stimulated cells: cells 
showed decrease of the monocytic surface marker CD 14 and 
increase of mature DC surface markers (CD83, CD86, MHCII). 
We could not observe further changes in the expression of 
surface markers after 72 hours of culture in the presence of 
cytokines. Therefore, we concluded that after 48 hours of total 
culture period, cells had completed DC differentiation (data not 
shown).  
 
As expected, cells did not display DC characteristics but showed 
a macrophage-like phenotype with high levels of CD 14 and low 
levels of CD1a if cultured in the absence of IL-4 (data not 
shown) (10). 
 
Cells harvested from cultures where the two-step differentiation 
and activation protocol was used showed significantly higher 
expression of CD83 and 3-fold increase in secretion of total IL-
12 (this trend did not reach statistical significance due to the large 
differences in maximal levels of IL-12 detected) compared to 
cells cultured with GM-CSF and IL-4 plus proinflammatory 
mediators from the beginning of cell culture (Fig. 2). IL-12 (p40)-
measurement correlated with measurement of total IL-12 (data 
not shown). Bioactive IL-12 (p70) could not be detected in any of 
the supernatants. Only after additional stimulation of DCs with 
soluble CD40Ligand and IFN-γ could production of IL-12 (p70) 
be observed (14). 
 
In summary, these experiments demonstrate that fully mature 
dendritic cells can be derived from monocytes within 48 hours. 
The sequential activation and differentiation strategy proved to 
be superior to activation from the beginning of cell culture. DCs 
generated with the two-step method will further be referred to as 
FastDC (Protocol 2). 
 
Fig. 2: Dendritic cells generated according to a 2-step protocol of 
differentiation and activation show significantly higher expression of the 
surface marker CD83 and secrete higher levels of IL-12. Monocytes cultured 
with GM-CSF/IL-4 were either stimulated with proinflammatory mediators at the 
initiation of culture or after 24 hours of culture. After 48 hours of total culture 
period cells were harvested. Expression of the mature DC surface marker CD83 
was determined by FACS (top) and culture supernatants were harvested for 
measurement of total IL-12  (IL-12 (p40) and IL-12 (p70), bottom). Data 
represent means ± SEM of three experiments with different donors. 
 
Comparison of FastDC with standard moDCs  
 
Next, we compared expression of activation markers on FastDC 
with those on standard monocyte-derived DCs (moDCs). 
Monocytes were either cultured with GM-CSF plus IL-4 for 48 
hours or stimulated with proinflammatory mediators for the last 
24 hours of culture. Alternatively, monocytes were cultured with 
GM-CSF plus IL-4 for five days and stimulated for another 2 
days (moDCs). Cell morphology was compared by light 
microscopy. Cells incubated with GM-CSF plus IL-4 alone were 
similar to the initial monocyte population. Obermaier et al.    
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Fig. 3: FastDC express equal levels of mature DC surface markers 
compared to standard monocyte-derived DCs (moDCs). Monocytes were 
cultured for 48 hours with GM-CSF plus IL-4 alone (top) or stimulated with 
proinflammatory mediators for the last 24 hours (middle). Expression of mature 
DC surface markers was compared with standard moDCs (bottom): monocytes 
were incubated with GM-CSF/IL-4 for 6 days followed by stimulation with 
proinflammatory mediators for another 2 days. Results of a representative FACS 
analysis out of five independent experiments are shown. 
 
FastDC were similar to monocytes in size, but developed fine 
cytoplasmic protrusions. In contrast, moDCs had long 
cytoplasmic veils and showed considerable increase in size (data 
not shown). FSC/SSC analysis confirmed the light microscopy 
findings (Fig. 3). Compared to cells incubated with GM-CSF plus 
IL-4 alone, stimulated FastDC showed increased FSC/SSC 
intensity; moDCs showed an even greater increase in FSC/SSC 
intensity. Next, we assessed the expression of activation markers 
on all three cell-types by FACS analysis. As described above, cells 
incubated with GM-CSF plus IL-4 alone downregulate CD 14 
and express moderate levels of CD86 and MHCII (Fig. 3, top). 
Stimulated FastDC displayed fully mature DC immunophenotype 
(CD83+CD14-CD86highMHCIIhigh). The expression of activation 
markers was comparable to that of stimulated moDCs (Fig. 3, 
middle and bottom). 
 
Identification of proinflammatory mediators 
required for maturation of FastDC  
 
Having established a reliable protocol to generate mature 
dendritic cells from monocytes within 48 hours, we wanted to 
identify the proinflammatory mediators required for optimal 
maturation of FastDC. To this end, we compared stimulation 
with four proinflammatory mediators (IL-6, IL-1β, TNF-α and 
PGE2) to stimulation with each of the proinflammatory 
mediators alone or stimulation with soluble CD40L trimer. 
 
CD 14+ c e l l s  w e r e  i n c u b a t e d  w i t h  G M - C S F  p l u s  I L - 4  f o r  2 4  
hours followed by 24 hours of stimulation. After 48 hours we 
examined expression of mature DC surface markers and 
secretion of total IL-12. We discovered that none of the 
proinflammatory mediators could induce DC maturation if used 
alone: cells did not express CD83, they only upregulated CD86 
and MHCII and they did not secrete IL-12. Only stimulation with 
PGE2 induced expression of the costimulatory molecules CD86 
and MHCII to levels similar to those of FastDC (Fig. 4). 
 
Fig. 4: A combination of four proinflammatory mediators is required for 
full maturation of FastDC. Monocytes were cultured with GM-CSF plus IL-4 
for 48 hours and stimulated with either the combination of all four 
proinflammatory mediators or with each of the mediators alone or with soluble 
CD40L trimer for the last 24 hours. Expression of mature DC surface markers 
was determined by FACS (top) and culture supernatants were harvested for 
measurement of total IL-12  (IL-12 (p40) and IL-12 (p70), bottom). Data 
represent means ± SEM of four experiments with different donors. 
 
Our findings are supported by prior studies having shown that 
only a combination of different proinflammatory mediators 
effectively induces DC maturation (11-13). 
 
Functionality of FastDC 
 
The ability to take up antigen is characteristic for immature DCs 
and is lost upon stimulation (4). To determine their endocytic 
capacity, monocytes were cultured with GM-CSF and IL-4 for 48 
hours and incubated with FITC-conjugated dextran at different 
time points: at the initiation of culture, after 12, 24 and 48 hours 
of culture. After 2 hours of incubation at 37°C cells were washed Obermaier et al.    
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and dextran-uptake was measured by FACS analysis. Continuous 
increase in the uptake of FITC-dextran could be observed. After 
24 hours cells already showed 10-fold increase in dextran-uptake 
(14). These findings suggest that monocytes incubated with GM-
CSF and IL-4 possess endocytic capacity and can be loaded with 
antigen. Upon maturation, endocytic capacity is rapidly lost (data 
not shown). 
 
A characteristic of mature DCs is their ability to effectively 
stimulate T cell responses. To assess the capacity of FastDC to 
induce antigen-specific T cell responses, FastDC were loaded 
with tetanus toxoid protein (TT) as a model antigen (Protocol 3). 
TT-loaded FastDC were cocultured with autologous T cells in 
the presence of CD40Ligand. Cocultures with unloaded FastDC 
and with monocytes cultured with GM-CSF and IL-4 were used 
as controls. After 5 days, antigen-specific proliferation of 
autologous T cells cocultured with TT-loaded FastDC could be 
detected in a (H3)-thymidine proliferation assay (14). In an 
additional set of experiments, T cells were restimulated with the 
different cell types at day 10 of the coculture. After 4 hours of 
restimulation coculture supernatants were harvested for the 
measurement of IFN-γ by ELISA. Only antigen loaded FastDC 
could induce a TH1 type immune response with high levels of 
IFN-γ (14). 
 
Advantages of FastDC 
 
Taken together, our experiments demonstrate that mature DCs 
can be generated from monocytes within 48 hours. FastDC 
display a fully mature DC immunophenotype (CD83+CD14-
CD86highMHCIIhigh) comparable to that of standard moDCs. 
Within the first 24 hours, monocytes incubated with GM-CSF 
and IL-4 display high endocytic capacity and can thus be 
effectively loaded with antigen. Compared to traditional 
protocols, generation of FastDC offers considerable advantages: 
the short period of in vitro culture (48 hours) not only reduces 
labor, cost and time but also renders cells less sensitive for 
external disruptive factors. Moreover, we found a greater 
reliability in the expression of surface markers on FastDC (> 
90% CD83+) and a greater stability and yield of mature DCs (up 
to 50% of the initial population of monocytes) compared to a 
standard protocol of 7 days. 
 
Yield and stability of FastDC 
 
For our experiments, we only used moncytes freshly isolated 
from PBMCs. MACS-purification proved to be superior to 
plastic adherence concerning purity and yield of isolated 
monocytes (purity > 95% vs. 80-90%). After MACS purification, 
the yield of monocytes was at least twice as high as after plastic 
adherence. From 100 ml of peripheral blood the average yield of 
monocytes by MACS was 25 million compared to 9 million by 
plastic adherence. Although a number of studies have shown 
significant differences between DCs generated from monocytes 
isolated by MACS or plastic adherence, we did not observe any 
differences concerning phenotype and function of FastDC. In 
both cases, up to 50% of the initial population of monocytes 
could be recovered after 48 hours. 
 
To evaluate stability of FastDC, we cultured fully mature FastDC 
in the absence of cytokines. Monocytes were incubated with GM-
CSF and IL-4 and stimulated for the last 24 hours of culture with 
proinflammatory mediators. After a total culture period of 48 
hours, FastDC were harvested, washed and cultured in complete 
medium without addition of cytokines or growth factors. 
Expression of mature DC surface markers remained stable for 48 
hours after removal of cytokines (data not shown). 
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PROTOCOLS 
 
Equipment 
 
50 ml pp-tubes (Greiner Bio-one GmbH, Frickenhausen, Germany) 
550 ml (175 cm2) tissue culture flasks with filter (Greiner Bio-one GmbH, Frickenhausen, Germany) 
Cell scraper (Sarstedt AG & Co, Nümbrecht, Germany) 
Tissue culture plates, 6 well, flat-bottom (Becton Dickinson Falcon, Heidelberg, Germany) 
 
Reagents and medium (see Materials & Methods) 
 
Protocol 1: Isolation of monocytes 
 
1.  Prepare medium for the culture of human PBMC: supplement 500 ml RPMI medium with 2% human AB serum, 2 mM L-
glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin (complete medium). 
2.  Full blood must be gained from volunteer healthy donors by venous punction. 
3.  Dilute the full heparinized (50 I.E Heparin/ml blood) blood with 0.9% sodium chloride in a ratio of 1:2. 
4.  Stratify 30 ml of the diluted blood on 15 ml of Ficoll-Hypaque (Biochrom, Berlin, Germany) in a 50 ml pp-tube. 
5.  Centrifuge cells for 20 minutes at a temperature of 20°C and a speed of 1000g.  
6.  After centrifugation a ring of PBMC gets visible in the interphase between Ficoll-Hypaque and the serum. Transfer the PBMC into 
a new 50 ml pp-tube by using a pipette. To wash the cells add sodium chloride up to the 45 ml mark of the tube. 
7.  Centrifuge the cells for 15 minutes at a temperature of 20°C and a speed of 520g. 
8.  To purify PBMC wash the cells twice in sodium chloride (0.9%) and centrifuge cells for 10 minutes at a temperature of 4°C and a 
speed of 300g. 
9.  Now either use the MACS CD14 isolation kit according to the manufacturer’s instruction to isolate monocytes or keep to the 
following instructions: resuspend the PBMC in complete medium. Resuspend cells isolated out of 50 ml of full blood in 20 ml of 
complete medium and transfer them into a 550 ml tissue culture flask. 
10.  Let the cells adhere for one hour in the incubator (37°C and 5% CO2).  
11.  After one hour control the cells microscopically and remove the non-adherent cell fraction. You can keep it for coculture 
experiments. To increase purity of the adherent monocytes rinse the culture flask twice with warm PBS. 
12.  Add 20 ml of fresh warm complete medium to the adherent cell fraction and incubate the cells for 24h at 37°C and 5% CO2. 
13.  After 24 hours the initially adherent monocytes come off and can be harvested. To optimize results use the cell scraper and rinse 
the culture flask twice with PBS. 
14.  Centrifuge cells for 10 minutes at a temperature of 4°C and a speed of 300g. 
15.  Count the monocytes and resuspend them in complete medium at a concentration of 0.75 to 1.5 million cells per ml. 
 
Protocol 2: Generation of FastDC from monocytes in vitro 
 
1.  After isolation (either by MACS (purity > 95%) or by collecting the plastic adherent fraction (purity 80-90%) of PBMC) resuspend 
monocytes in complete medium at a concentration of 0,75 to 1,5 million cells per ml. After MACS purification the yield of 
monocytes was at least twice as high compared to plastic adherence (average yield from 100 ml of peripheral blood: MACS, 25 
million monocytes; plastic adherence, 9 million monocytes). 
2.  Before culturing the monocytes you always should screen their morphology and purity by FACS analysis. 
3.  Plate monocytes in a 6 well tissue culture plate at a density of 1.5 to 3 million cells per dish in 2 ml of medium. 
4.  Add 500 U/ml IL-4 and 1000 U/ml GM-CSF to the cell suspension. 
5.  Incubate the cells for 24 hours at 37°C and 5% CO2. 
6.  After 24 hours add a cocktail of proinflammatory mediators to the cell suspension: 1000 U/ml TNF-α, 10 ng/ml IL-1β, 10 ng/ml 
IL-6 plus 1 µM PGE2. 
7.  Incubate the cells again for 24 hours at 37°C and 5% CO2. 
8.  After a total culture period of 48 hours harvest the dendritic cells (FastDC). 
 
Protocol 3: Antigen-loading of FastDC 
 
1.  Resuspend monocytes in complete medium at a concentration of 0.75 to 1.5 million cells per ml and plate monocytes in a 6 well 
tissue culture plate at a density of 1.5 to 3 million cells per dish in 2 ml of medium. 
2.  Add 500 U/ml IL-4 and 1000 U/ml GM-CSF to the cell suspension. 
3.  Add the antigen to the cell suspension. 
4.  After 24 hours of incubation with the antigen add a cocktail of proinflammatory mediators to the cell suspension to induce DC 
maturation: 1000 U/ml TNF-α, 10 ng/ml IL-1β, 10 ng/ml IL-6 plus 1 µM PGE2. 
5.  Incubate the cells again for 24 hours at 37°C and 5% CO2 and harvest them after a total culture period of 48 hours. 